BNP Paribas Financial Markets Acquires New Position in Oscar Health, Inc. (NYSE:OSCR)

BNP Paribas Financial Markets acquired a new stake in Oscar Health, Inc. (NYSE:OSCR) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 43,873 shares of the company’s stock, valued at approximately $590,000.

Other hedge funds also recently bought and sold shares of the company. Ameriprise Financial Inc. boosted its stake in shares of Oscar Health by 3,062.3% in the fourth quarter. Ameriprise Financial Inc. now owns 976,563 shares of the company’s stock valued at $13,125,000 after purchasing an additional 945,682 shares during the period. Ancient Art L.P. raised its holdings in Oscar Health by 66.8% during the fourth quarter. Ancient Art L.P. now owns 2,950,753 shares of the company’s stock worth $39,658,000 after purchasing an additional 1,182,134 shares in the last quarter. Ardsley Advisory Partners LP raised its holdings in Oscar Health by 2.0% during the fourth quarter. Ardsley Advisory Partners LP now owns 1,125,000 shares of the company’s stock worth $15,120,000 after purchasing an additional 22,400 shares in the last quarter. Comerica Bank grew its position in shares of Oscar Health by 41.3% during the fourth quarter. Comerica Bank now owns 128,810 shares of the company’s stock worth $1,731,000 after acquiring an additional 37,675 shares during the last quarter. Finally, Park West Asset Management LLC grew its position in shares of Oscar Health by 186.9% during the fourth quarter. Park West Asset Management LLC now owns 925,000 shares of the company’s stock worth $12,432,000 after acquiring an additional 602,585 shares during the last quarter. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Insider Transactions at Oscar Health

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total value of $410,750.00. Following the completion of the transaction, the director now owns 64,512 shares in the company, valued at $1,059,932.16. This represents a 27.93% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 24.39% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on OSCR shares. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Wall Street Zen downgraded Oscar Health from a “buy” rating to a “hold” rating in a research note on Thursday. Two research analysts have rated the stock with a sell rating, three have given a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $20.08.

Oscar Health Trading Down 1.6%

NYSE OSCR opened at $14.14 on Friday. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.79. The company has a 50-day moving average of $13.66 and a 200-day moving average of $14.58. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market cap of $3.54 billion, a P/E ratio of -706.65 and a beta of 1.75.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. The business had revenue of $3 billion during the quarter, compared to analysts’ expectations of $2.87 billion. During the same quarter in the previous year, the business earned $0.62 EPS. The company’s revenue for the quarter was up 42.2% on a year-over-year basis. As a group, equities analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.